Cyrus Vaziri

4.9k total citations
81 papers, 3.8k citations indexed

About

Cyrus Vaziri is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Cyrus Vaziri has authored 81 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 35 papers in Oncology and 34 papers in Cancer Research. Recurrent topics in Cyrus Vaziri's work include DNA Repair Mechanisms (48 papers), Cancer-related Molecular Pathways (26 papers) and Carcinogens and Genotoxicity Assessment (18 papers). Cyrus Vaziri is often cited by papers focused on DNA Repair Mechanisms (48 papers), Cancer-related Molecular Pathways (26 papers) and Carcinogens and Genotoxicity Assessment (18 papers). Cyrus Vaziri collaborates with scholars based in United States, Japan and United Kingdom. Cyrus Vaziri's co-authors include Douglas V. Faller, Satoshi Tateishi, Haruo Ohmori, Ning Guo, Damien Slater, Xiaohui Bi, C. Peter Downes, Laura R. Barkley, Stuart L. Schreiber and Paul Nghiem and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Cyrus Vaziri

76 papers receiving 3.7k citations

Peers

Countries citing papers authored by Cyrus Vaziri

Since Specialization

Citations

This map shows the geographic impact of Cyrus Vaziri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyrus Vaziri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyrus Vaziri more than expected).

Fields of papers citing papers by Cyrus Vaziri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyrus Vaziri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyrus Vaziri. The network helps show where Cyrus Vaziri may publish in the future.

Co-authorship network of co-authors of Cyrus Vaziri

This figure shows the co-authorship network connecting the top 25 collaborators of Cyrus Vaziri. A scholar is included among the top collaborators of Cyrus Vaziri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyrus Vaziri. Cyrus Vaziri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of Next Generation Cell-Permeable Peptide Inhibitors for the Oncological Target MAGE-A4 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Jacqueline L. Norris‐Drouin, (unknown), Konstantin Popov, Cyrus Vaziri, Albert A. Bowers, Kenneth H. Pearce	0
2	The RING finger E3 ligase RNF25 protects DNA replication forks independently of its canonical roles in ubiquitin signaling 2025 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), Xingyuan Zhang, Yang Yang, Christine A. Mills, (unknown), Natalie K. Barker, (unknown), Di Wu, Laura E. Herring, Junya Tomida, Jessica L. Bowser, Cyrus Vaziri	0
3	The DNA Damage Response (DDR) landscape of endometrial cancer defines discrete disease subtypes and reveals therapeutic opportunities 2024 ·NAR Cancer ·(unknown), Sayali Joseph, Di Wu, Jessica L. Bowser, Cyrus Vaziri	4
4	MAPK14/p38α shapes the molecular landscape of endometrial cancer and promotes tumorigenic characteristics 2024 ·Cell Reports ·Sayali Joseph, Xingyuan Zhang, (unknown), Di Wu, Victoria Bae‐Jump, Scott K. Lyons, (unknown), (unknown), Laura E. Herring, Blake R. Rushing, Jessica L. Bowser, Cyrus Vaziri	2
5	The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregation 2023 ·Nucleic Acids Research ·(unknown), Patrik Risteski, Yang Yang, Huan Chen, (unknown), Andrea Walens, (unknown), Melissa A. Troester, Laura E. Herring, Jonathan Chernoff, Iva M. Tolić, Jessica L. Bowser, Cyrus Vaziri	7
6	VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer 2023 ·Genes & Cancer ·(unknown), Jennifer E. Klomp, Clint A. Stalnecker, Craig M. Goodwin, Yanzhe Gao, (unknown), Cyrus Vaziri, Kirsten L. Bryant, Channing J. Der, Adrienne D. Cox	5
7	RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Andrea Walens, (unknown), (unknown), (unknown), (unknown), Xiaohua Gao, Alina M. Hamilton, Erin L. Kirk, Michael I. Love, Gaorav P. Gupta, Charles M. Perou, Cyrus Vaziri, Katherine A. Hoadley, Melissa A. Troester	9
8	Unravelling roles of error-prone DNA polymerases in shaping cancer genomes 2021 ·Oncogene ·Cyrus Vaziri, Igor B. Rogozin, Qisheng Gu, Di Wu, Tovah A. Day	25
9	Rad18 confers hematopoietic progenitor cell DNA damage tolerance independently of the Fanconi Anemia pathwayin vivo 2016 ·Nucleic Acids Research ·Yang Yang, Jonathan C. Poe, Lisong Yang, Andrew Fedoriw, (unknown), Terry Magnuson, Zhiguo Li, Yuri Fedoriw, Kimi Araki, Yanzhe Gao, Satoshi Tateishi, Stefanie Sarantopoulos, Cyrus Vaziri	15
10	A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis 2016 ·Nature Communications ·Yanzhe Gao, (unknown), Alicia Greenwalt, Dennis Goldfarb, Feng Yan, Yang Yang, (unknown), Kenneth H. Pearce, Satoshi Tateishi, Michael B. Major, Cyrus Vaziri	58
11	Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21Cip1 2013 ·Journal of Molecular and Cellular Cardiology ·Zhaokang Cheng, (unknown), Mauricio Rojas, Cyrus Vaziri, Christopher P. Mack, Joan M. Taylor	22
12	Rad18-mediated Translesion Synthesis of Bulky DNA Adducts Is Coupled to Activation of the Fanconi Anemia DNA Repair Pathway 2010 ·Journal of Biological Chemistry ·(unknown), Komaraiah Palle, Aditi U. Gurkar, Satoshi Tateishi, Gary M. Kupfer, Cyrus Vaziri	54
13	Separate Roles of Structured and Unstructured Regions of Y-Family DNA Polymerases 2009 ·Advances in protein chemistry and structural biology ·Haruo Ohmori, Tomo Hanafusa, Eiji Ohashi, Cyrus Vaziri	38
14	The developmentally-regulated Smoc2 gene is repressed by aryl-hydrocarbon receptor (Ahr) signaling 2008 ·Gene ·Peijun Liu, (unknown), Rebeka R. Merson, K. Albrecht, Cyrus Vaziri	16
15	A p53-Dependent Checkpoint Pathway Prevents Rereplication 2003 ·Molecular Cell ·Cyrus Vaziri, Sandeep Saxena, Yesu Jeon, Charles Lee, Kazutaka Murata, Yuichi Machida, Nikhil Wagle, Deog Su Hwang, Anindya Dutta	4
16	Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN) 2001 ·Cell Death and Differentiation ·(unknown), (unknown), (unknown), Cyrus Vaziri, (unknown), Timothy J. Eberlein, Remco A. Spanjaard	38
17	RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F. 2000 ·PubMed ·Gerald V. Denis, Cyrus Vaziri, Ning Guo, Douglas V. Faller	137
18	Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. 1998 ·PubMed ·Cyrus Vaziri, (unknown), Douglas V. Faller	91
19	Down-regulation of Platelet-derived Growth Factor Receptor Expression during Terminal Differentiation of 3T3-L1 Pre-adipocyte Fibroblasts 1996 ·Journal of Biological Chemistry ·Cyrus Vaziri, Douglas V. Faller	42
20	Repression of Platelet-Derived Growth Factor β-Receptor Expression by Mitogenic Growth Factors and Transforming Oncogenes in Murine 3T3 Fibroblasts 1995 ·Molecular and Cellular Biology ·Cyrus Vaziri, Douglas V. Faller	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact